I am amazed at how quickly now the weeks seem to be ticking off. Already we are nearly 1/3 finished with April.
April has already been good to stockholders with the 2 PRs already published. I expect it to get even better. ** Good to shareholders in better knowing what we own, not the share price ** The share price situation has become laughable in the face of such strong development support for B-CV19.
May will be a knockout month for even more great news (as in EUA approval) IMO and by June IPIX should be sailing with results pretty much known, though not yet officially published.
Everybody knows the chances of success for B are quite high due to a Selectivity Index of 426, trial admin allowing dosing days to extend from 3 to 5 which shows that safety concerns are negligible, GMU giving a key speech at Natl Assoc of Virology conference in July after having studied B for over a year, Dr. DeGrado's solid endorsement of B and defensin mimetics as a revolutionary new arm of medicine, FINRA putting IPIX on the SHO list which should lessen share price suppressing analog computer trading, and Leo stating that OTHER Brilacidin testing is advancing quite well and showing B has potential across most all types of viruses.
The above makes me shake my head as to when those that are betting against B and IPIX will start taking actions to limit their potentially catastrophic losses. They know they have lost, you would think they would at least try to minimize the damage.
News 
Market Data 
Discover 
